Co-Authors
This is a "connection" page, showing publications co-authored by Matthew Hall and Kelli Wilson.
Connection Strength
0.286
-
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay. ACS Pharmacol Transl Sci. 2020 Dec 11; 3(6):1352-1360.
Score: 0.228
-
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Front Pharmacol. 2020; 11:592737.
Score: 0.058